Sclerostin: an Emerging Target for the Treatment of Cancer-Induced Bone Disease.
about
Sclerostin: an Emerging Target for the Treatment of Cancer-Induced Bone Disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Sclerostin: an Emerging Target for the Treatment of Cancer-Induced Bone Disease.
@en
Sclerostin: an Emerging Target for the Treatment of Cancer-Induced Bone Disease.
@nl
type
label
Sclerostin: an Emerging Target for the Treatment of Cancer-Induced Bone Disease.
@en
Sclerostin: an Emerging Target for the Treatment of Cancer-Induced Bone Disease.
@nl
prefLabel
Sclerostin: an Emerging Target for the Treatment of Cancer-Induced Bone Disease.
@en
Sclerostin: an Emerging Target for the Treatment of Cancer-Induced Bone Disease.
@nl
P2860
P1476
Sclerostin: an Emerging Target for the Treatment of Cancer-Induced Bone Disease
@en
P2093
Jesus Delgado-Calle
P2860
P2888
P304
P356
10.1007/S11914-017-0403-Y
P577
2017-12-01T00:00:00Z